Adverse reactions to trimethoprim-sulfamethoxazole among children with human immunodeficiency virus infection

Pediatric Infectious Disease Journal

Volumn 16, Issue 11, 1997, Pages 1028-1031

  Rieder, Michael J ^a,b,c   King, Susan M ^b   Read, Stan ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

Author keywords

Acquired immunodeficiency syndrome; Adverse drug reactions; Human immunodeficiency virus; Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; SULFONAMIDE;

ARTICLE; ERYTHEMA MULTIFORME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME;

ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; MALE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0030658826     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199711000-00005     Document Type: Article

References (20)

1. Greenberger PA, Patterson R. Management of drug allergy in patients with acquired immunodeficiency syndrome. J Allergy Clin Immunol 1987;79:484-8.
2. Mijch AM, Hoy JF. Unexplained fever and drug reactions as clues to HIV infection. Med J Aust 1993;158:188-9.
3. White DA, Zaman MK. Medical management of AIDS patients: pulmonary disease. Med Clin North Am 1992;76:19-44.
4. Van der Ven AJAM, Koopmans PP, Vree TB, Van der Meer JWM. Adverse reactions to co-trimoxazole in HIV infection. Lancet 1991;338:431-2.
5. Kelly JW, Dooley DP, Lattuada CP, Smith CE. A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency disease. Clin Infect Dis 1992;14:1034-9.
6. Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 1993;167:180-5.
7. Kletzel M, Beck S, Elser J, Shock N, Burks W. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions. Am J Dis Child 1991;145:1428-9.
8. Van der Ven AJM, Koopmans PP, Vree TB, Van der Meer JWM. Drug intolerance in HIV disease. J Antimicrob Chemother 1995;34:1-5.
9. Chanock SJ, Luginbuhl LM, McIntosh K, Lipshultz SE. Life-threatening reaction to trimethoprim/sulfamethoxazole in pediatric human immunodeficiency disease. Pediatr 1994; 93:519-21.
10. Rieder MJ, Uetrecht J, Shear NH, Cannon M, Miller M, Spielberg SP. Diagnosis of sulphonamide hypersensitivity reactions by in vitro "rechallenge" with hydroxylamine metabolites. Ann Intern Med 1989;110:286-9.
11. Gutman LT. The use of trimethoprim-sulfamethoxazole in children: a review of adverse reactions and indications. Pediatr Infect Dis 1984;3:349-57.
12. Palusci VJ, Kaul A, Lawrence RM, Haines KA, Kwittken PL. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Pediatr Infect Dis J 1996;15:456-62.
13. Sullivan TJ. Allergic reactions to drugs: a review of reactions to drugs not in the beta lactam antibiotic class. J Allergy Clin Immunol 1984;74:594-9.
14. Carrington DM, Earl HS, Sullivan TJ. Studies of human IgE to a sulfonamide determinant. J Allergy Clin Immunol 1987; 79:442-7.
15. Gruchalla RS, Sullivan TJ. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. J Allergy Clin Immunol 1991;88:784-92.
16. Carr A, Tindall B, Penny R, Cooper DA. In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. Clin Exp Immunol 1993;94:21-5.
17. Lee BL, Wong D, Benowitz NL, Summan PM. Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin Pharmacol Ther 1993;53:529-35.
18. Carr A, Gross AS, Hoskins JM, Penny R, Cooper DA. Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients. AIDS 1994;8:333-7.
19. Rieder MJ, Krause R, Bird IA, Dekaban G. Toxicity of sulphonamide reactive metabolites in HIV-infected and non-infected cells. J AIDS 1995;8:134-40.
20. Shear NH, Spielberg SP. In vitro evaluation of a toxic metabolite of sulfadiazine. Can J Physiol Pharmacol 1985;63: 1370-2.